BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai IL, You JF, Chern YJ, Tsai WS, Chiang JM, Hsieh PS, Hung HY, Hsu YJ. The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision. World J Surg Oncol 2021;19:116. [PMID: 33849564 DOI: 10.1186/s12957-021-02223-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kawamura H, Miyakawa T, Tsujimoto Y, Yamamoto R, Watanabe N, Honda M. The clinical effect of total mesorectal excision with lateral lymph node dissection for lower rectal cancer: A systematic review and meta-analysis. Ann Cancer Res Therap 2022;30:106-114. [DOI: 10.4993/acrt.30.106] [Reference Citation Analysis]
2 Li JJ, Zhang ZB, Xu SY, Zhang CR, Yang XF, Duan YX. Robotic versus Laparoscopic Total Mesorectal Excision Surgery in Rectal Cancer: Analysis of Medium-Term Oncological Outcomes. Surg Innov 2022;:15533506221100283. [PMID: 35507460 DOI: 10.1177/15533506221100283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yu G, Lu W, Jiao Z, Qiao J, Ma S, Liu X. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy. World J Surg Oncol 2021;19:305. [PMID: 34663341 DOI: 10.1186/s12957-021-02415-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li Z, Li S, Tao H, Zhan Y, Ni K, Gong J, Li G. Higher titer hepatitis B core antibody predicts a higher risk of liver metastases and worse survival in patients with colorectal cancer. World J Surg Oncol 2021;19:251. [PMID: 34446030 DOI: 10.1186/s12957-021-02369-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zeman M, Czarnecki M, Chmielik E, Idasiak A, Skałba W, Strączyński M, Paul PJ, Czarniecka A. The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection. World J Surg Oncol 2021;19:154. [PMID: 34020673 DOI: 10.1186/s12957-021-02262-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]